KRAS amplification is also a reported mechanism of resistance to sotorasib in a patient with KRAS p.G12C mutant NSCLC and a patient with KRAS p.G12C mutant colon cancer10. This evidence concerns the gene KRAS and non-small cell lung carcinoma.